title: [The association between NAT2 polymorphism and anti-tuberculosis drug-induced hepatitis].
authors.affiliation: Department of Medcine, Shenzhen Third Peoples Hospital, Guangdong Medical College, Shenzhen 518020, China.
authors.forename: Yu-Mei
authors.initials: YM
authors.lastname: Wu
authors.forename: Zi-Yi
authors.initials: ZY
authors.lastname: Luo
authors.forename: Hong-Mei
authors.initials: HM
authors.lastname: Zhang
authors.forename: Jin-Fu
authors.initials: JF
authors.lastname: Peng
authors.forename: Sai-Yun
authors.initials: SY
authors.lastname: Liu
authors.forename: Min
authors.initials: M
authors.lastname: Wang
mesh_terms: D000293:Adolescent; D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects*; D001191:Arylamine N-Acetyltransferase / Q000235:genetics*; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D055815:Young Adult
chemical_list: D000995:Antitubercular Agents; D001191:Arylamine N-Acetyltransferase; C478900:NAT2 protein, human; D007538:Isoniazid